Neurocognitive Impairment and Its Long-term Impact on Adults With Congenital Heart Disease. Prog Cardiovasc Dis 2018;61(3-4):287-293
Date
08/18/2018Pubmed ID
30118722DOI
10.1016/j.pcad.2018.08.002Scopus ID
2-s2.0-85052798723 (requires institutional sign-in at Scopus site) 26 CitationsAbstract
It is well-recognized now that adult survivors with congenital heart disease (ACHD) are at risk for non-cardiac co-morbidities and complications that can impact symptoms and clinical outcomes. Cognitive dysfunction, in particular, is common in this population, but likely an under-recognized and undertreated cause for long-term morbidity. Abnormal cognitive function has a major impact on all aspects of quality of life, including employment opportunities, educational attainment, and the ability to maintain meaningful social relationships, such as marriage. The association and impact of cognitive dysfunction in ACHD is not fully understood and continues to be understudied. Nevertheless, cognitive dysfunction may be a potentially modifiable risk factor in this population that is amenable to intervention, which may in-turn translate to improved outcomes. This review summarizes our current understanding of the prevalence, impact, and management of cognitive dysfunction in ACHD.
Author List
Cohen S, Earing MGAuthor
Scott B. Cohen MD Associate Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
AdultCognitive Dysfunction
Heart Defects, Congenital
Humans
Prevalence
Quality of Life
Risk Factors
Survivors
